XML 79 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Fair Value Measurement
12 Months Ended
Sep. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 8 – Fair Value Measurement
 
The Fair Value Measurements and Disclosures Topic of the Financial Accounting Standards Board (FASB) Accounting Standards Codification defines fair value, establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements.
 
Under the FASB’s authoritative guidance on fair value measurements, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Fair Value Measurements Topic of the FASB Accounting Standards Codification establishes a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date.
 
Assets and liabilities measured at fair value are to be categorized into one of the three hierarchy levels based on the inputs used in the valuation. The Company classifies assets and liabilities in their entirety based on the lowest level of input significant to the fair value measurement. There were no transfers between levels for all periods presented. The three levels are defined as follows:
 
·
Level 1: Observable inputs based on quoted prices (unadjusted) in active markets for identical assets or liabilities.
 
·
Level 2: Observable inputs based on quoted prices for similar assets and liabilities in active markets, or quoted prices for identical assets and liabilities in inactive markets.
 
·
Level 3: Unobservable inputs that reflect an entity’s own assumptions about what inputs a market participant would use in pricing the asset or liability based on the best information available in the circumstances.
 
A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
 
The FASB fair value guidance also applies to certain assets that indirectly impact the consolidated financial statements, including pension plan assets. While the Company does not have direct control over these assets, the Company is indirectly impacted by subsequent fair value adjustments to these assets and the actual return on these assets not only affects the net periodic benefit cost but also the amount included in the consolidated balance sheet. The Company uses the fair value hierarchy to measure the fair value of assets held in the pension plan.
 
The following table presents the pension plan assets financial instruments carried at fair value as of September 30, 2014 and 2013 in accordance with the fair value hierarchy:
 
 
 
Quoted prices in
active markets for
identical assets
 
Significant other
observable inputs
 
Significant
unobservable
Inputs
 
 
 
(Level 1)
 
(Level 2)
 
(Level 3)
 
September 30, 2014
 
 
 
 
 
 
 
 
 
 
Money Market Separate Account
 
$
-
 
$
327,000
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
Total plan assets
 
$
-
 
$
327,000
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
September 30, 2013
 
 
 
 
 
 
 
 
 
 
Money Market Separate Account
 
$
-
 
$
315,000
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
Total plan assets
 
$
-
 
$
315,000
 
$
-
 
 
In the second quarter of 2013, as a result of a decision to dispose of a significant portion of the Products reporting unit, the Company performed an interim impairment test of long lived assets and goodwill and determined that the remaining goodwill totaling $4.0 million was impaired and that $2.8 million of the $4.8 million Acquired Customer Base was also impaired.
 
The fair value of the Acquired Customer Base of $2.0 million was calculated using a discounted cash flow approach, which included unobservable inputs classified as Level 3 within the fair value hierarchy. The amount and timing of future cash flows were based on the Company’s operational budgets. The Company used the assistance of independent consulting firms to develop valuation assumptions.
 
As a result of the sales of the Gamma Medical Probe and Lead Paint businesses (see Note 3) in 2014, there are no remaining intangible assets in the Products reporting unit.